In the early 1990s, Merck faced a number of challenges due to significant changes in its competitive and regulatory environment (eg, increase in the power of pharmaceutical customers wanted to managed care organizations has resulted in price pressure and a review of the entire U.S. President Clinton's health care industry) . The case describes the company under its previous CEO, and first under Ray Gilmartin, the new CEO. Discussion of the strategic, organizational, cultural and management challenges that face Merck and Gilmartin program change from 1994 to 1998, which was aimed at helping Merck address these issues. "Hide
by Michael Beer, Perry L. Fagan Source: Harvard Business School 20 pages. Publication Date: March 29, 1999. Prod. #: 499054-PDF-ENG